Welcome to LookChem.com Sign In|Join Free
  • or
N-<(phenylmethoxy)carbonyl>-4-oxo-(S)-proline ethyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

83507-89-5

Post Buying Request

83507-89-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

83507-89-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 83507-89-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,3,5,0 and 7 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 83507-89:
(7*8)+(6*3)+(5*5)+(4*0)+(3*7)+(2*8)+(1*9)=145
145 % 10 = 5
So 83507-89-5 is a valid CAS Registry Number.

83507-89-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name N-Cbz-4-keto-L-proline ethyl ester

1.2 Other means of identification

Product number -
Other names N-[(phenylmethoxy)carbonyl]-4-oxo-(S)-proline ethyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:83507-89-5 SDS

83507-89-5Relevant academic research and scientific papers

Synthesis of N-butyloxycarbonylalanyl-1,4-dioxa-7-azaspiro[4,4]nonane-8(s)-carboxylic acid ethyl ester

Slavinskaya,Chipens,Sile,Korchagova,Katkevich,Grigor'eva,Lukevits

, p. 568 - 570 (1996)

A four-step method has been developed for the synthesis of N-butyloxycarbonylalanyl-1,4-dioxa-7-azaspiro-[4,4]nonane-8(S)-carboxylic acid ethyl ester through the formation of N-benzyloxycarbonyl-1,4-dioxa-7-azaspiro[4,4]nonane-8(S)-carboxylic acid ethyl e

Thrombin inhibitors from the freshwater cyanobacterium Anabaena compacta

Anas, Andrea Roxanne J.,Kisugi, Takaya,Umezawa, Taiki,Matsuda, Fuyuhiko,Okino, Tatsufumi,Campitelli, Marc R.,Quinn, Ronald J.

, p. 1546 - 1552,7 (2012/12/12)

Bioassay-guided investigation of the cyanobacterium Anabaena compacta extracts afforded spumigin J (1) and the known thrombin inhibitor spumigin A (2). The absolute configuration of 1 was analyzed by advanced Marfey's methodology. Compounds 1 and 2 inhibi

Thrombin inhibitors from the freshwater cyanobacterium Anabaena compacta

Anas, Andrea Roxanne J.,Kisugi, Takaya,Umezawa, Taiki,Matsuda, Fuyuhiko,Campitelli, Marc R.,Quinn, Ronald J.,Okino, Tatsufumi

, p. 1546 - 1552 (2013/01/15)

Bioassay-guided investigation of the cyanobacterium Anabaena compacta extracts afforded spumigin J (1) and the known thrombin inhibitor spumigin A (2). The absolute configuration of 1 was analyzed by advanced Marfey's methodology. Compounds 1 and 2 inhibi

Concise, stereoselective route to the four diastereoisomers of 4-methylproline

Murphy, Annabel C.,Mitova, Maya I.,Blunt, John W.,Munro, Murray H.G.

experimental part, p. 806 - 809 (2009/04/07)

The full stereochemical characterization of 4-methylproline, a rare amino acid found in a number of peptidic secondary metabolites, has often been hindered by long reaction sequences or low stereoselectivity in the synthesis leading to reference samples. The preparation of the four diastereoisomers of 4-methylproline by a concise and stereoselective route is presented and features a six-step route with late-stage stereodivergence, good stereoselectivity for both cis- and trans-series (75% and 88% de, respectively), and good overall yields (cumulative yields of 30-40%). Additional data on the Marfey's derivatives of the stereoisomers are also presented.

Angiotensin Converting Enzyme Inhibitors: Spirapril and Related Compounds

Smith, Elizabeth M.,Swiss, Gerald F.,Neustadt, Bernard R.,McNamara, Paul,Gold, Elijah H.,et al.

, p. 1600 - 1606 (2007/10/02)

The synthesis of spirapril (5), spiraprilat (25), their RSS stereoisomers, and their glycyl (18b) and lysyl (36, 37) analogues is described.These compounds were evaluated in vivo for inhibition of angiotensin converting enzyme (ACE), and selected compounds were evaluated for in vitro ACE inhibition (spirapril ID50 16 μg/kg; spiraprilat IC50 0.8 nM, ID50 8 μg/kg).In anesthetized rats, iv, esters 5 and 36 are more potent than enalapril, and diacids 25 and 37 are more potent than enalaprilat in vitro.In the conscious rats, orally, 5 and enalapril (2) showed potent and sustained activity at doses of 0.03-1 and 0.1-1 mg/kg, respectively.From this work, spirapril was selected for clinical evaluation as an antihypertensive agent.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 83507-89-5